Halozyme Therapeutics, Inc. (HALO) — Analyst estimates
Consensus analyst estimates for Halozyme Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 526.24M | 2.53 | 2 |
| 2027 | 536.43M | 2.62 | 2 |
| 2028 | 2.18B | 11.17 | 2 |
| 2029 | 2.01B | 10.13 | 1 |
| 2030 | 1.78B | 8.9 | 1 |
Consensus analyst estimates by fiscal year.